Guardion Health Sciences, Inc. (NASDAQ:GHSI) Sees Significant Decrease in Short Interest

Guardion Health Sciences, Inc. (NASDAQ:GHSI) was the target of a large decrease in short interest during the month of August. As of August 15th, there was short interest totalling 55,600 shares, a decrease of 5.1% from the July 31st total of 58,600 shares. Based on an average daily trading volume, of 41,700 shares, the short-interest ratio is currently 1.3 days. Currently, 5.5% of the shares of the company are sold short.

Guardion Health Sciences Stock Up 5.8 %

NASDAQ GHSI opened at $14.67 on Wednesday. The company has a market capitalization of $18.78 million, a P/E ratio of -3.65 and a beta of 0.91. Guardion Health Sciences has a 12-month low of $5.01 and a 12-month high of $18.00. The firm has a 50-day moving average price of $10.34 and a two-hundred day moving average price of $9.28.

Guardion Health Sciences Announces Dividend

The firm also recently disclosed a dividend, which will be paid on Monday, September 23rd. Shareholders of record on Monday, September 9th will be issued a $5.00 dividend. The ex-dividend date of this dividend is Monday, September 9th.

Guardion Health Sciences Company Profile

Guardion Health Sciences, Inc, a clinical nutrition company, develops and distributes clinically supported dietary supplements and medical foods in North America, Europe, and internationally. The company offers GlaucoCetin, a dietary supplement to support mitochondrial function with additional antioxidants to help reduce oxidative stress and increase blood flow throughout the body for enhanced eye support and ocular health; and Lumega-Z, a medical food that replenishes and restores the macular protective pigment.